Clinical Trials

160 enrolled

Urinary Bladder Neoplasms

NCT04322318 2026-02-24

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

256 enrolled

Wilms Tumor

NCT04947254 2026-02-19

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

200 enrolled

Prostatic Neoplasms

NCT05320406 2026-02-12

REVELUTION

94 enrolled 13 charts

Prostatic Neoplasms

NCT04879940 2026-02-05

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

26 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT07202247 2026-02-04

Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial

60 enrolled

Prostatic Neoplasms

NCT05568550 2026-01-30

Pembro With Radiation With or Without Olaparib

64 enrolled

Prostatic Neoplasms

NCT07364071 2026-01-27

SENTRY

150 enrolled

Prostatic Neoplasms

NCT06391034 2026-01-07

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

161 enrolled

Prostatic Neoplasms

NCT03809000 2025-12-30

STEEL

188 enrolled 25 charts

Prostatic Neoplasms

NCT06378866 2025-12-26

DIVINE

532 enrolled

Prostatic Neoplasms

NCT04175431 2025-12-18

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

100 enrolled

Prostate Adenocarcinoma

NCT04025372 2025-12-15

INTREPId (INTermediate Risk Erection PreservatIon Trial)

234 enrolled

Prostatic Neoplasms

NCT06369610 2025-11-14

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

110 enrolled

Oligometastatic Prostate Carcinoma

NCT04216290 2025-11-12

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

95 enrolled

Urinary Bladder Neoplasms

NCT06150417 2025-11-12

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

200 enrolled

Prostatic Neoplasms

NCT06244004 2025-10-22

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

125 enrolled

Prostatic Neoplasms

NCT06528210 2025-09-23

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT06255223 2025-09-03

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

35 enrolled

Carcinoma, Renal Cell

NCT04319783 2025-08-21

DECREASE

65 enrolled

Prostatic Neoplasms

NCT07100184 2025-08-03

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

30 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07043608 2025-07-02

ZAMBONI

20 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT06992232 2025-05-28

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

144 enrolled

Prostatic Neoplasms

NCT06582446 2025-03-11

HypoElect

30 enrolled

Prostatic Neoplasms

NCT03763253 2025-02-07

IP2-ATLANTA

433 enrolled

Prostatic Neoplasms

NCT06686381 2025-02-05

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

80 enrolled

Muscle-invasive Bladder Cancer

NCT02662062 2025-01-27

PCR-MIB

28 enrolled 15 charts

Urinary Bladder Neoplasms

NCT06409910 2024-12-09

AMPORA

204 enrolled

Post-Operative Prostate Cancer

NCT03702179 2024-12-05

IMMUNOPRESERVE

32 enrolled 19 charts

Invasive Bladder Cancer

NCT03486197 2024-11-20

Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma

12 enrolled 10 charts

Carcinoma, Transitional Cell

NCT06310369 2024-07-22

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

50 enrolled

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04176081 2024-01-24

SChLAP/IDC

208 enrolled

BreastGenitourinary

Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms

NCT03649841 2023-10-26

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

10 enrolled 7 charts

Prostatic Neoplasms

NCT05912205 2023-06-22

Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation

30 enrolled

Carcinoma, Transitional Cell

NCT01751438 2023-04-27

Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)

180 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

2 enrolled 8 charts

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT05212857 2022-03-16

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

160 enrolled

Prostatic Neoplasms

NCT02508636 2021-10-12

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

11 enrolled 17 charts

Prostatic Neoplasms

NCT00214136 2021-08-04

Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes

30 enrolled 8 charts

Prostatic Neoplasms

NCT00006111 2021-02-21

Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract

53 enrolled

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT03432780 2021-01-22

QRT-SOGUG

134 enrolled

Prostatic Neoplasms

NCT04585932 2021-01-20

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00006365 2020-10-22

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

138 enrolled

Prostatic Neoplasms

NCT03763851 2020-03-12

Cannabis Oil and Radiation Therapy for the Management of Pain

BreastGenitourinaryThoracic

100 enrolled

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT04031378 2019-07-24

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

100 enrolled

Prostatic Neoplasms

NCT02057939 2019-06-26

STREAM

38 enrolled 12 charts

Prostatic Neoplasms

NCT03950362 2019-05-16

PREVERT

67 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT00528866 2019-04-24

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

80 enrolled 11 charts

Prostatic Neoplasms

NCT03419130 2018-12-07

Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer

Phase 2 Withdrawn

Infiltrating Bladder Urothelial Carcinoma

NCT00055601 2018-06-15

Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer

97 enrolled 8 charts